Accretive Health (AH) says it will postpone the release of its financial results for Q4 and...


Accretive Health (AH) says it will postpone the release of its financial results for Q4 and FY12, as well as its previously announced investor conference call scheduled for February 27. The company is reviewing the manner in which it recognizes revenue for its revenue cycle management agreements, and based on information available to date, if a change becomes necessary, it may be required to restate prior-period financial statements. Shares -9.6% AH.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs